{{Rsnum
|rsid=6766709
|Chromosome=3
|position=137051421
|Orientation=plus
|GMAF=0.2544
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 8.0 | 30.4 | 61.6
| HCB | 22.6 | 51.8 | 25.5
| JPT | 16.8 | 50.4 | 32.7
| YRI | 0.7 | 7.5 | 91.8
| ASW | 0.0 | 7.0 | 93.0
| CHB | 22.6 | 51.8 | 25.5
| CHD | 29.4 | 50.5 | 20.2
| GIH | 0.0 | 29.7 | 70.3
| LWK | 0.0 | 2.7 | 97.3
| MEX | 10.3 | 37.9 | 51.7
| MKK | 0.6 | 24.4 | 75.0
| TSI | 4.9 | 32.4 | 62.7
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6766709
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084216
|Annotation=In a multi-stage case-control study of Type I Diabetes Mellitus patients from Finland, Iceland and the British Isles, this SNP(rs6766709) was part of a haplotype associated with risk of Diabetic Nephropathy . The other tag SNPs for the haplotype are rs17374749,rs1866813 and rs16844489.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus, Type 1; Diabetic Nephropathies
|Curation Level=Curated
|PharmGKB Accession ID=PA164857069
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6766709
|overall_frequency_n=103
|overall_frequency_d=124
|overall_frequency=0.830645
|n_genomes=50
|n_genomes_annotated=0
|n_haplomes=83
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}